Acquisition of direct antiviral effector functions by CMV-specific CD4+ T lymphocytes with cellular maturation
Joseph P. Casazza(The University of Texas Southwestern Medical Center), Richard A. Koup(Aaron Diamond AIDS Research Center), Melissa Precopio(Idera Pharmaceuticals (United States)), Daniel C. Douek(Institut de Recherche Vaccinale), Brenna J. Hill(National Institute of Allergy and Infectious Diseases), Laura E. Ruff(Institut de Recherche Vaccinale), Mario Roederer(National Institutes of Health), Jason M. Brenchley(National Institutes of Health), David A. Price(University Hospital of Wales), Michael R. Betts(University of Pennsylvania)
Cited by 333
Related Papers
A human memory T cell subset with stem cell–like properties
|Nature Medicine|2011|2k
Rational Design of Envelope Identifies Broadly Neutralizing Human Monoclonal Antibodies to HIV-1
|Science|2010|1.8k
Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications
|Science|2020|1.7k
Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation
|Journal of Immunological Methods|2003|1.6k
T-cell quality in memory and protection: implications for vaccine design
|Nature reviews. Immunology|2008|1.6k